BNP Paribas Asset Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
DGM
OAG
BNP Paribas Asset Management's INSM Position: Q2 2026 in Review
BNP Paribas Asset Management increased its Insmed (INSM) stake by 1.6% in Q2 2026, buying an estimated $915K and bringing the position to 475,307 shares worth $50.7M. The position accounts for 0.05% of the portfolio, ranked #332.
BNP Paribas Asset Management first reported a position in INSM in Q1 2022 and has held it in 18 quarters since. The position peaked at $76.5M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- BNP Paribas Asset Management held 475,307 shares of Insmed worth $50.7M as of Q2 2026.
- BNP Paribas Asset Management bought 7,554 Insmed shares in Q2 2026, an estimated $915K.
- Insmed made up 0.05% of BNP Paribas Asset Management's portfolio in Q2 2026, its #332 holding.
- BNP Paribas Asset Management first reported a position in Insmed in Q1 2022 and has held it in 18 quarters since.
- BNP Paribas Asset Management's Insmed position peaked at $76.5M in Q1 2026.
- 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.